Literature DB >> 17486110

Exercise can prevent and even reverse adverse effects of androgen suppression treatment in men with prostate cancer.

D A Galvão1, D R Taaffe, N Spry, R U Newton.   

Abstract

Side effects accompanying androgen deprivation therapy (ADT), including sarcopenia, loss of bone mass and reduction in muscle strength, can compromise physical function, particularly in older patients. Exercise, specifically resistance training, may be an effective and cost-efficient strategy to limit or even reverse some of these adverse effects during and following therapy. In this review, we discuss common morphological and physiological ADT-related side effects or 'Androgen Deprivation and Sarcopenia-Related Disorders' and the existing clinical trials incorporating physical exercise in prostate cancer patients receiving active therapy. Further, training concepts and guidelines are provided for prescribing resistance exercise programs for this population.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17486110     DOI: 10.1038/sj.pcan.4500975

Source DB:  PubMed          Journal:  Prostate Cancer Prostatic Dis        ISSN: 1365-7852            Impact factor:   5.554


  30 in total

1.  Prostate cancer: Androgen deprivation therapy and bone loss.

Authors:  Eitan Amir; Ian F Tannock
Journal:  Nat Rev Urol       Date:  2009-12       Impact factor: 14.432

Review 2.  The effects of resistance exercise on physical performance and health-related quality of life in prostate cancer patients: a systematic review.

Authors:  T Hasenoehrl; M Keilani; T Sedghi Komanadj; M Mickel; M Margreiter; M Marhold; R Crevenna
Journal:  Support Care Cancer       Date:  2015-05-24       Impact factor: 3.603

Review 3.  Clinical exercise interventions in prostate cancer patients--a systematic review of randomized controlled trials.

Authors:  Freerk T Baumann; Eva M Zopf; Wilhelm Bloch
Journal:  Support Care Cancer       Date:  2011-10-12       Impact factor: 3.603

4.  Skeletal response to resistance and impact training in prostate cancer survivors.

Authors:  Kerri M Winters-Stone; Jessica C Dobek; Jill A Bennett; Gianni F Maddalozzo; Christopher W Ryan; Tomasz M Beer
Journal:  Med Sci Sports Exerc       Date:  2014-08       Impact factor: 5.411

Review 5.  Sarcopenic obesity and the pathogenesis of exercise intolerance in heart failure with preserved ejection fraction.

Authors:  Bharathi Upadhya; Mark J Haykowsky; Joel Eggebeen; Dalane W Kitzman
Journal:  Curr Heart Fail Rep       Date:  2015-06

6.  Perceptions of masculinity and body image in men with prostate cancer: the role of exercise.

Authors:  David Michael Langelier; Prue Cormie; William Bridel; Christopher Grant; Natalia Albinati; Jena Shank; Julia Teresa Daun; Tak S Fung; Colin Davey; S Nicole Culos-Reed
Journal:  Support Care Cancer       Date:  2018-04-13       Impact factor: 3.603

7.  A phase III clinical trial of exercise modalities on treatment side-effects in men receiving therapy for prostate cancer.

Authors:  Robert U Newton; Dennis R Taaffe; Nigel Spry; Robert A Gardiner; Gregory Levin; Bradley Wall; David Joseph; Suzanne K Chambers; Daniel A Galvão
Journal:  BMC Cancer       Date:  2009-06-29       Impact factor: 4.430

8.  Is there a role for complementary therapy in the management of leukemia?

Authors:  Kathleen M Wesa; Barrie R Cassileth
Journal:  Expert Rev Anticancer Ther       Date:  2009-09       Impact factor: 4.512

Review 9.  Exercise in prevention and management of cancer.

Authors:  Robert U Newton; Daniel A Galvão
Journal:  Curr Treat Options Oncol       Date:  2008-08-13

10.  A randomized controlled trial of an exercise intervention targeting cardiovascular and metabolic risk factors for prostate cancer patients from the RADAR trial.

Authors:  Daniel A Galvão; Nigel Spry; Dennis R Taaffe; James Denham; David Joseph; David S Lamb; Greg Levin; Gillian Duchesne; Robert U Newton
Journal:  BMC Cancer       Date:  2009-12-02       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.